837 related articles for article (PubMed ID: 18087165)
1. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
2. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
[TBL] [Abstract][Full Text] [Related]
3. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
Horiguchi S; Tanaka Y; Uchida T; Chazono H; Ookawa T; Sakurai D; Okamoto Y
Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
[TBL] [Abstract][Full Text] [Related]
4. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.
Ishii M; Koyama A; Iseki H; Narumi H; Yokoyama N; Kojima N
Int Immunopharmacol; 2010 Sep; 10(9):1041-6. PubMed ID: 20584630
[TBL] [Abstract][Full Text] [Related]
5. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
[TBL] [Abstract][Full Text] [Related]
6. Roles of carbohydrates on Cry j 1, the major allergen of Japanese cedar pollen, in specific T-cell responses.
Okano M; Kino K; Takishita T; Hattori H; Ogawa T; Yoshino T; Yokoyama M; Nishizaki K
J Allergy Clin Immunol; 2001 Jul; 108(1):101-8. PubMed ID: 11447389
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
8. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
9. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
Masuda K
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
[TBL] [Abstract][Full Text] [Related]
14. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial.
Xiao JZ; Kondo S; Yanagisawa N; Takahashi N; Odamaki T; Iwabuchi N; Miyaji K; Iwatsuki K; Togashi H; Enomoto K; Enomoto T
Clin Exp Allergy; 2006 Nov; 36(11):1425-35. PubMed ID: 17083353
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
Murakami D; Kubo K; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
Ito Y; Takahashi Y; Fujita T; Fukuyama S
Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
[TBL] [Abstract][Full Text] [Related]
18. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
Hiroi T; Takaiwa F
Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
[TBL] [Abstract][Full Text] [Related]
19. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract.
Amar SM; Harbeck RJ; Sills M; Silveira LJ; O'Brien H; Nelson HS
J Allergy Clin Immunol; 2009 Jul; 124(1):150-156.e1-5. PubMed ID: 19523672
[TBL] [Abstract][Full Text] [Related]
20. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis.
Fujimura T; Yonekura S; Horiguchi S; Taniguchi Y; Saito A; Yasueda H; Inamine A; Nakayama T; Takemori T; Taniguchi M; Sakaguchi M; Okamoto Y
Clin Immunol; 2011 Apr; 139(1):65-74. PubMed ID: 21300571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
